<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00792844</url>
  </required_header>
  <id_info>
    <org_study_id>1-Seto</org_study_id>
    <nct_id>NCT00792844</nct_id>
  </id_info>
  <brief_title>Comparison of Two Formulations of Bio-K</brief_title>
  <official_title>Comparison of Two Formulations of Lactobacillus Acidophilus and Lactobacillus Casei in the Prevention of Antibiotic-Associated Diarrhea: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McMaster University</source>
  <brief_summary>
    <textblock>
      Main research Question: The investigators would like to find out if both the Bio-K&#xD;
      (lactobacillus acidophilus and lactobacillus casei) drink and capsule are equally effective&#xD;
      in the prevention of diarrhea associated with antibiotic use.&#xD;
&#xD;
      Why is this research project important? About 25% of patients who use antibiotics may develop&#xD;
      diarrhea as a side effect. Symptoms are mild and consist of watery diarrhea and abdominal&#xD;
      pain. Some patients may develop a more severe form of diarrhea, called clostridium&#xD;
      difficile-associated diarrhea. Clostridium difficile-associated diarrhea may lead to more&#xD;
      serious consequences like inflammation of the large bowel and in some cases, death. There are&#xD;
      some studies that suggest Bio-K drink, a probiotic preparation containing lactobacillus&#xD;
      acidophilus and lactobacillus casei, decreases the risk of diarrhea from antibiotic use. As a&#xD;
      result, St. Joseph's Healthcare has recently to use Bio-K routinely to try to reduce risk of&#xD;
      patients developing diarrhea. No other Hamilton hospitals use Bio-K routinely as there is not&#xD;
      strong evidence about the effectiveness of Bio-K for the prevention of diarrhea. This study&#xD;
      will provide more information about Bio-K's effectiveness in the prevention of diarrhea&#xD;
      associated with antibiotic use as both a capsule and a drink.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2009</start_date>
  <completion_date type="Anticipated">May 2009</completion_date>
  <primary_completion_date type="Anticipated">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antibiotic-associated diarrhea</measure>
    <time_frame>30 days after termination of antibiotic</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Antibiotic-Associated Diarrhea</condition>
  <arm_group>
    <arm_group_label>Bio-K capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 capsule of lactobacillus acidophilus and lactobacillus casei (50 billion live bacteria) daily for duration of antibiotic therapy and 7 days after or until discharge, whichever comes first</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bio-K liquid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>98 g of lactobacillus acidophilus and lactobacillus casei (50 billion live bacteria) daily for the duration of antibiotic treatment and for 7 days after termination of antibiotics or until hospital discharge, whichever comes first</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no Bio-K</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No lactobacillus product - standard infection control procedures (i.e. handwashing, etc.)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bio-K capsule formulation</intervention_name>
    <description>Bio-K 1 capsule formulation daily for the duration of antibiotic treatment and for 7 days after termination of antibiotics or until hospital discharge, whichever occurs first</description>
    <arm_group_label>Bio-K capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bio-K drink</intervention_name>
    <description>Bio-K 98 g of diary-free soy beverage formulation for the duration of antibiotic treatment and for 7 days after termination of antibiotics or until hospital discharge, whichever occurs first</description>
    <arm_group_label>Bio-K liquid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  speak English&#xD;
&#xD;
          -  capable of providing consent&#xD;
&#xD;
          -  reachable by telephone within the next three months&#xD;
&#xD;
          -  willing to comply with study protocols&#xD;
&#xD;
          -  age over 65 years&#xD;
&#xD;
          -  prescribed clindamycin, fluoroquinolones or cephalosporin for more than one dose&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ICU patients&#xD;
&#xD;
          -  transplant patients&#xD;
&#xD;
          -  patients on immunosuppressant medications (prednisone greater than 50 mg/day for 7&#xD;
             days, azathioprine, cyclosporine, cyclophosphamide, tacrolimus, sirolimus,&#xD;
             methotrexate, mycophenolate, anti-TNF agents, interleukin-2 chemotherapy)&#xD;
&#xD;
          -  HIV patients with CD4+ count less than 250 cells/mm3&#xD;
&#xD;
          -  neutropenic patients with total neutrophil count less than 500&#xD;
&#xD;
          -  patients with prosthetic heart valves&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gloria Seto, BSchPhm</last_name>
    <phone>905-522-1155</phone>
    <phone_ext>33803</phone_ext>
    <email>gseto@stjosham.on.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Joseph's Healthcare Hamilton - Charlton Campus</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Gloria Seto</last_name>
      <email>gseto@stjosham.on.ca</email>
    </contact>
    <investigator>
      <last_name>Gloria Seto, BScPhm</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <study_first_submitted>November 17, 2008</study_first_submitted>
  <study_first_submitted_qc>November 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2008</study_first_posted>
  <last_update_submitted>November 17, 2008</last_update_submitted>
  <last_update_submitted_qc>November 17, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2008</last_update_posted>
  <responsible_party>
    <name_title>Gloria Seto</name_title>
    <organization>St. Joseph's Healthcare Hamilton</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

